Notch inhibitors for cancer treatment
I Espinoza, L Miele - Pharmacology & therapeutics, 2013 - Elsevier
Notch signaling is an evolutionarily conserved cell signaling pathway involved in cell fate
during development, stem cell renewal and differentiation in postnatal tissues. Roles for …
during development, stem cell renewal and differentiation in postnatal tissues. Roles for …
The notch ligand JAGGED1 as a target for anti-tumor therapy
D Li, M Masiero, AH Banham, AL Harris - Frontiers in oncology, 2014 - frontiersin.org
The Notch pathway is increasingly attracting attention as a source of therapeutic targets for
cancer. Ligand-induced Notch signaling has been implicated in various aspects of cancer …
cancer. Ligand-induced Notch signaling has been implicated in various aspects of cancer …
[HTML][HTML] The oncogenic role of Jagged1/Notch signaling in cancer
M Xiu, Y Liu, B Kuang - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Aberrant activation of Notch signaling plays an oncogenic role in cancer development.
Jagged1 (JAG1) is an important Notch ligand that triggers Notch signaling through cell-cell …
Jagged1 (JAG1) is an important Notch ligand that triggers Notch signaling through cell-cell …
Notch regulation of gastrointestinal stem cells
ES Demitrack, LC Samuelson - The Journal of physiology, 2016 - Wiley Online Library
The gastrointestinal (GI) tract epithelium is continuously replenished by actively cycling stem
and progenitor cells. These cell compartments are regulated to balance proliferation and …
and progenitor cells. These cell compartments are regulated to balance proliferation and …
[HTML][HTML] Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
Gastric cancer (GC) is the third leading cause of cancer mortality worldwide. Although
surgical resection is a potentially curative approach for localized cases of GC, most cases of …
surgical resection is a potentially curative approach for localized cases of GC, most cases of …
Gastric cancer stem cells: evidence, potential markers, and clinical implications
Gastric cancer is a significant global health problem. It is the fifth most common cancer and
third leading cause of cancer-related death worldwide (Torre et al. in CA Cancer J Clin 65 …
third leading cause of cancer-related death worldwide (Torre et al. in CA Cancer J Clin 65 …
Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance
M Hashemi, S Hasani, S Hajimazdarany… - International journal of …, 2022 - Elsevier
Cancer is a challenging to treat disease with a high mortality rate worldwide, nevertheless
advances in science has led to a decrease in the number of death cases caused by cancer …
advances in science has led to a decrease in the number of death cases caused by cancer …
Dysregulation of cellular signaling in gastric cancer
The pathogenesis of gastric cancer is complex and related to multiple factors. Dysregulation
of intracellular signaling pathways represents a common pathogenic mechanism and may …
of intracellular signaling pathways represents a common pathogenic mechanism and may …
Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms
The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with lower risks for
esophageal, gastric and colon cancers as well as other solid tumors. The antitumor effect of …
esophageal, gastric and colon cancers as well as other solid tumors. The antitumor effect of …
A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression
HL Li, QY Li, MJ Jin, CF Lu, ZY Mu, WY Xu… - Journal of Cancer …, 2021 - Springer
Abstract Background The Hippo pathway is widely considered to inhibit cell growth and play
an important role in regulating the size of organs. However, recent studies have shown that …
an important role in regulating the size of organs. However, recent studies have shown that …